C1q/tumor necrosis factor-related protein 9 protects against acute myocardial injury through an adiponectin receptor I-AMPK-dependent mechanism

Molecular and Cellular Biology

Volumn 35, Issue 12, 2015, Pages 2173-2185

  Kambara, Takahiro ^a   Shibata, Rei ^a   Ohashi, Koji ^a   Matsuo, Kazuhiro ^a   Hiramatsu Ito, Mizuho ^a   Enomoto, Takashi ^a   Yuasa, Daisuke ^a   Ito, Masanori ^a   Hayakawa, Satoko ^a   Ogawa, Hayato ^a   Aprahamian, Tamar ^b   Walsh, Kenneth ^b   Murohara, Toyoaki ^a   Ouchi, Noriyuki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN RECEPTOR 1; CYTOKINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LIPOPOLYSACCHARIDE; PROTEIN CTRP9; UNCLASSIFIED DRUG; ADIPONECTIN; ADIPONECTIN RECEPTOR; ADIPONECTIN RECEPTOR 1, MOUSE; CTRP9 PROTEIN, MOUSE; GLYCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GAIN OF FUNCTION MUTATION; GENE EXPRESSION; GENE SILENCING; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART PROTECTION; INFLAMMATION; LOSS OF FUNCTION MUTATION; MALE; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; CELL CULTURE; COMPLICATION; GENETICS; HEART MUSCLE; IMMUNOLOGY; KNOCKOUT MOUSE; PATHOLOGY;

MUS; MUS MUSCULUS;

ADIPONECTIN; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CELLS, CULTURED; GLYCOPROTEINS; INFLAMMATION; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; MYOCYTES, CARDIAC; RATS; RECEPTORS, ADIPONECTIN;

EID: 84929416512     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01518-14     Document Type: Article

References (28)

1. Wolk R, Berger P, Lennon RJ, Brilakis ES, Somers VK. 2003. Body mass index: a risk factor for unstable angina and myocardial infarction in patients with angiographically confirmed coronary artery disease. Circulation 108: 2206-2211. http://dx.doi.org/10.1161/01.CIR.0000095270.85646.E8.
2. Orlander PR, Goff DC, Morrissey M, Ramsey DJ, Wear ML, Labarthe DR, Nichaman MZ. 1994. The relation of diabetes to the severity of acute myocardial infarction and post-myocardial infarction survival in Mexican-Americans and non-Hispanic whites. The Corpus Christi Heart Project. Diabetes 43:897-902.
3. Ouchi N, Parker JL, Lugus JJ, Walsh K. 2011. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11:85-97. http://dx.doi.org/10.1038/nri2921.
4. Shibata R, Ohashi K, Murohara T, Ouchi N. 2014. The potential of adipokines as therapeutic agents for cardiovascular disease. Cytokine Growth Factor Rev 25:483-487. http://dx.doi.org/10.1016/j.cytogfr.2014.07.005.
5. Ouchi N, Walsh K. 2012. Cardiovascular and metabolic regulation by the adiponectin/C1q/tumor necrosis factor-related protein family of proteins. Circulation 125:3066-3068. http://dx.doi.org/10.1161/circulationaha.112.114181.
6. Wong GW, Krawczyk SA, Kitidis-Mitrokostas C, Ge G, Spooner E, Hug C, Gimeno R, Lodish HF. 2009. Identification and characterization of CTRP9, a novel secreted glycoprotein, from adipose tissue that reduces serum glucose in mice and forms heterotrimers with adiponectin. FASEB J 23:241-258. http://dx.doi.org/10.1096/fj.08-114991.
7. Hwang YC, Woo Oh S, Park SW, Park CY. 2014. Association of serum C1q/TNF-related protein-9 (CTRP9) concentration with visceral adiposity and metabolic syndrome in humans. Int J Obes 38:1207-1212. http://dx.doi.org/10.1038/ijo.2013.242.
8. Peterson JM, Wei Z, Seldin MM, Byerly MS, Aja S, Wong GW. 2013. CTRP9 transgenic mice are protected from diet-induced obesity and metabolic dysfunction. Am J Physiol Regul Integr Comp Physiol 305:R522-R533. http://dx.doi.org/10.1152/ajpregu.00110.2013.
9. Wei Z, Lei X, Petersen PS, Aja S, Wong GW. 2014. Targeted deletion of C1q/TNF-related protein 9 increases food intake, decreases insulin sensitivity, and promotes hepatic steatosis in mice. Am J Physiol Endocrinol Metab 306:E779-E790. http://dx.doi.org/10.1152/ajpendo.00593.2013.
10. Zheng Q, Yuan Y, Yi W, Lau WB, Wang Y, Wang X, Sun Y, Lopez BL, Christopher TA, Peterson JM, Wong GW, Yu S, Yi D, Ma XL. 2011. C1q/TNF-related proteins, a family of novel adipokines, induce vascular relaxation through the adiponectin receptor-1/AMPK/eNOS/nitric oxide signaling pathway. Arterioscler Thromb Vasc Biol 31:2616-2623. http://dx.doi.org/10.1161/atvbaha.111.231050.
11. Uemura Y, Shibata R, Ohashi K, Enomoto T, Kambara T, Yamamoto T, Ogura Y, Yuasa D, Joki Y, Matsuo K, Miyabe M, Kataoka Y, Murohara T, Ouchi N. 2013. Adipose-derived factor CTRP9 attenuates vascular smooth muscle cell proliferation and neointimal formation. FASEB J 27:25-33. http://dx.doi.org/10.1096/fj.12-213744.
12. Kambara T, Ohashi K, Shibata R, Ogura Y, Maruyama S, Enomoto T, Uemura Y, Shimizu Y, Yuasa D, Matsuo K, Miyabe M, Kataoka Y, Murohara T, Ouchi N. 2012. CTRP9 protein protects against myocardial injury following ischemia-reperfusion through AMP-activated protein kinase (AMPK)-dependent mechanism. J Biol Chem 287:18965-18973. http://dx.doi.org/10.1074/jbc.M112.357939.
13. Sun Y, Yi W, Yuan Y, Lau WB, Yi D, Wang X, Wang Y, Su H, Wang X, Gao E, Koch WJ, Ma XL. 2013. C1q/tumor necrosis factor-related protein-9, a novel adipocyte-derived cytokine, attenuates adverse remodeling in the ischemic mouse heart via protein kinase A activation. Circulation 128:S113-S120. http://dx.doi.org/10.1161/CIRCUATIONAHA.112.000010.
14. Ouchi N, Kobayashi H, Kihara S, Kumada M, Sato K, Inoue T, Funahashi T, Walsh K. 2004. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem 279:1304-1309. http://dx.doi.org/10.1074/jbc.M310389200.
15. Kobayashi H, Ouchi N, Kihara S, Walsh K, Kumada M, Abe Y, Funahashi T, Matsuzawa Y. 2004. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res 94:e27-e31. http://dx.doi.org/10.1161/01.RES.0000119921.86460.37.
16. Mu J, Brozinick JT, Jr, Valladares O, Bucan M, Birnbaum MJ. 2001. A role for AMP-activated protein kinase in contraction-and hypoxia-regulated glucose transport in skeletal muscle. Mol Cell 7:1085-1094. http://dx.doi.org/10.1016/S1097-2765(01)00251-9.
17. Valenzuela DM, Murphy AJ, Frendewey D, Gale NW, Economides AN, Auerbach W, Poueymirou WT, Adams NC, Rojas J, Yasenchak J, Chernomorsky R, Boucher M, Elsasser AL, Esau L, Zheng J, Griffiths JA, Wang X, Su H, Xue Y, Dominguez MG, Noguera I, Torres R, Macdonald LE, Stewart AF, DeChiara TM, Yancopoulos GD. 2003. High-throughput engineering of the mouse genome coupled with highresolution expression analysis. Nat Biotechnol 21:652-659. http://dx.doi.org/10.1038/nbt822.
18. Watanabe Y, Shibata R, Ouchi N, Kambara T, Ohashi K, Jie L, Inoue Y, Murohara T, Komori K. 2014. Adiponectin ameliorates endotoxininduced acute cardiac injury. Biomed Res Int 2014:382035. http://dx.doi.org/10.1155/2014/382035.
19. Shibata R, Sato K, Pimentel DR, Takemura Y, Kihara S, Ohashi K, Funahashi T, Ouchi N, Walsh K. 2005. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK-and COX-2-dependent mechanisms. Nat Med 11:1096-1103. http://dx.doi.org/10.1038/nm1295.
20. Hayakawa S, Ohashi K, Shibata R, Kataoka Y, Miyabe M, Enomoto T, Joki Y, Shimizu Y, Kambara T, Uemura Y, Yuasa D, Ogawa H, Matsuo K, Hiramatsu-Ito M, van den Hoff MJ, Walsh K, Murohara T, Ouchi N. 2015. Cardiac myocyte-derived follistatin-like 1 prevents renal injury in a subtotal nephrectomy model. J Am Soc Nephrol 26:636-646. http://dx.doi.org/10.1681/ASN.2014020210.
21. Frangogiannis NG, Smith CW, Entman ML. 2002. The inflammatory response in myocardial infarction. Cardiovasc Res 53:31-47. http://dx.doi.org/10.1016/S0008-6363(01)00434-5.
22. Peng T, Lu X, Feng Q. 2005. Pivotal role of gp91phox-containing NADH oxidase in lipopolysaccharide-induced tumor necrosis factor-alpha expression and myocardial depression. Circulation 111:1637-1644. http://dx.doi.org/10.1161/01.CIR.0000160366.50210.E9.
23. Hao E, Lang F, Chen Y, Zhang H, Cong X, Shen X, Su G. 2013. Resveratrol alleviates endotoxin-induced myocardial toxicity via the Nrf2 transcription factor. PLoS One 8:e69452. http://dx.doi.org/10.1371/journal.pone.0069452.
24. Ogura Y, Ouchi N, Ohashi K, Shibata R, Kataoka Y, Kambara T, Kito T, Maruyama S, Yuasa D, Matsuo K, Enomoto T, Uemura Y, Miyabe M, Ishii M, Yamamoto T, Shimizu Y, Walsh K, Murohara T. 2012. Therapeutic impact of follistatin-like 1 on myocardial ischemic injury in preclinical models. Circulation 126:1728-1738. http://dx.doi.org/10.1161/circulationaha.112.115089.
25. Gordon JW, Shaw JA, Kirshenbaum LA. 2011. Multiple facets of NF-κB in the heart: to be or not to NF-κB. Circ Res 108:1122-1132. http://dx.doi.org/10.1161/circresaha.110.226928.
26. O'Neill LA, Hardie DG. 2013. Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature 493:346-355. http://dx.doi.org/10.1038/nature11862.
27. Fisslthaler B, Fleming I. 2009. Activation and signaling by the AMPactivated protein kinase in endothelial cells. Circ Res 105:114-127. http://dx.doi.org/10.1161/circresaha.109.201590.
28. Parker-Duffen JL, Nakamura K, Silver M, Zuriaga MA, MacLauchlan S, Aprahamian TR, Walsh K. 2014. Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo. J Biol Chem 289:16200-16213. http://dx.doi.org/10.1074/jbc.M114.548115.